Furthermore, a study conducted by Wang et al. [77] revealed that metformin can reduce renal tubulointerstitial fibrosis, especially in the early stage of DN, with a significant increase in autophagy and a decrease in the expression of fibrotic biomarkers, such as fibronectin and type I collagen in kidney tissue. The gene discussed is FN1; the disease is liver dysplastic nodule.